[ad_1]
Weekly coronavirus deaths have risen by 1,937 in England and Wales, a 40% increase from the previous increase and the second consecutive week the total has reached four figures.
The Office of National Statistics (ONS), which counts death certificates when COVID-19 It is mentioned, it has reported a rise of 558 (40.5%) in the previous seven days, when the figure stood at 1,379.
Last week’s figure was first time since June that weekly coronavirus deaths had exceeded 1,000.
Live updates on coronavirus from the UK and around the world
The latest data for the week through November 6 brings the total number of COVID-19 deaths in England and Wales to 59,473.
This number is different from the total issued by the UK government, which records people who died within 28 days of a positive coronavirus test.
Use the Chrome browser for a more accessible video player
Modern Vaccine: ‘100% effective against severe COVID’
When all causes of death are taken into account, 11,812 people died in the week to November 6 in England and Wales, 1,481 more than the five-year average.
Use the Chrome browser for a more accessible video player
Modern vaccine: ‘No evidence of waning immunity’
It is the third week in a row that the number of people who die is higher than average.
The data showed that the number of deaths related to the coronavirus increased in all regions of England and Wales.
North West England had 568 COVID-19-related deaths in the first week of November, the highest number in the area since mid-May.
It was a similar situation in Yorkshire and the Humber: the 329 deaths recorded there are the highest number since the week ending May 15.
There were 152 deaths in northeast England in the latest ONS figures, the highest number since the week ending May 22.
:: Subscribe to the daily podcast on Apple Podcasts, Google Podcasts, Spotify, Spreaker
It comes after reports that two different vaccines they have worked well in rehearsals.
The American company Moderna said its inoculation may be 94.5% effective against the virus, a week after Pfizer and BioNTech published preliminary results of the third phase trials suggesting its vaccine is 90% effective. %.
